Voquezna — CareFirst (Caremark)
relief of heartburn associated with non-erosive gastroesophageal reflux disease in adults
Preferred products
- proton pump inhibitor (PPI)
Initial criteria
- Patient age ≥ 18 years
- Patient meets ONE of the following: inadequate treatment response to on-demand or intermittent proton pump inhibitor (PPI) therapy; intolerance to a PPI; contraindication that would prohibit a trial of a PPI
- Request is for Voquezna 10 mg tablets
Approval duration
4 weeks